Blue Trust Inc. lessened its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 5.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 69,850 shares of the company’s stock after selling 4,138 shares during the quarter. Blue Trust Inc.’s holdings in Procter & Gamble were worth $10,010,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also made changes to their positions in PG. Invesco Ltd. raised its holdings in Procter & Gamble by 21.4% in the second quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock valued at $2,608,785,000 after acquiring an additional 2,880,895 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in Procter & Gamble by 100.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company’s stock worth $782,607,000 after acquiring an additional 2,741,924 shares in the last quarter. Amundi increased its position in shares of Procter & Gamble by 26.3% in the 3rd quarter. Amundi now owns 10,682,455 shares of the company’s stock valued at $1,606,748,000 after purchasing an additional 2,222,560 shares during the last quarter. Lazard Asset Management LLC increased its position in shares of Procter & Gamble by 66.3% in the 2nd quarter. Lazard Asset Management LLC now owns 5,504,749 shares of the company’s stock valued at $877,014,000 after purchasing an additional 2,195,560 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in shares of Procter & Gamble by 8.3% in the 3rd quarter. Franklin Resources Inc. now owns 22,850,345 shares of the company’s stock valued at $3,510,955,000 after purchasing an additional 1,752,481 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
NYSE PG opened at $144.19 on Thursday. The company has a fifty day moving average of $153.85 and a two-hundred day moving average of $149.84. The company has a market capitalization of $335.10 billion, a PE ratio of 21.36, a P/E/G ratio of 5.08 and a beta of 0.41. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $174.80. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is presently 62.67%.
Insider Buying and Selling at Procter & Gamble
In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of Procter & Gamble stock in a transaction on Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the transaction, the insider directly owned 44,735 shares of the company’s stock, valued at $7,259,595.80. The trade was a 25.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Marc S. Pritchard sold 95,903 shares of the company’s stock in a transaction on Friday, January 23rd. The shares were sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the completion of the sale, the insider owned 182,607 shares of the company’s stock, valued at approximately $27,601,048.05. This trade represents a 34.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 348,618 shares of company stock valued at $55,462,643. 0.20% of the stock is owned by company insiders.
Trending Headlines about Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Investors are rotating into defensive, dividend-rich consumer staples as recession odds rise, which supports demand for PG stock as a low-beta hedge. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG)
- Positive Sentiment: New OLAY peptide research was presented at a dermatology conference and P&G plans to integrate proprietary peptide technologies into product formulas—an R&D catalyst that could support premium pricing and brand value over time. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
- Positive Sentiment: Recent session saw PG outperform the market on a prior close, reflecting investor preference for staples amid broader weakness. This shows defensive demand can provide near-term support. Procter & Gamble (PG) Ascends While Market Falls
- Neutral Sentiment: Analysts expect P&G’s upcoming fiscal Q3 results to show low single-digit EPS growth—this raises the bar modestly: a beat could lift the stock, while a slight miss may reinforce current caution. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
- Neutral Sentiment: Market commentary and analyst notes on consumer goods (including P&G and peers) are circulating, offering mixed takes that could influence near-term analyst revisions but contain no single decisive catalyst. Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Costco (COST)
- Negative Sentiment: TD Cowen cut its price target to $142 from $156 and kept a Hold rating, citing oil-related input-cost inflation tied to geopolitical tensions—this analyst action puts downward pressure on sentiment and could limit near-term upside. TD Cowen Adjusts Price Target on Procter & Gamble to $142 from $156; Maintains Hold Rating
- Negative Sentiment: Reports say Deutsche Bank has lowered expectations for P&G, and coverage notes broadly point to cost pressures (including oil-related input inflation from Middle East tensions) that could compress margins if raw-material costs accelerate. Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price
- Negative Sentiment: Coverage summarizing analyst downgrades highlights Iran-war related cost risks and has contributed to recent negative headlines and downgrades that weigh on sentiment. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More
Analyst Ratings Changes
A number of equities analysts recently commented on PG shares. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a research note on Friday, January 16th. Barclays set a $155.00 price target on Procter & Gamble in a report on Friday, January 16th. Jefferies Financial Group raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the stock from $156.00 to $179.00 in a research report on Tuesday, December 16th. Erste Group Bank lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Tuesday, March 24th. Finally, Wells Fargo & Company restated an “overweight” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Tuesday, February 17th. Twelve research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $167.06.
Check Out Our Latest Analysis on Procter & Gamble
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
